1. Home
  2. CYCC vs JRSH Comparison

CYCC vs JRSH Comparison

Compare CYCC & JRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCC
  • JRSH
  • Stock Information
  • Founded
  • CYCC 1992
  • JRSH 2016
  • Country
  • CYCC Malaysia
  • JRSH United States
  • Employees
  • CYCC N/A
  • JRSH N/A
  • Industry
  • CYCC Biotechnology: Pharmaceutical Preparations
  • JRSH Apparel
  • Sector
  • CYCC Health Care
  • JRSH Consumer Discretionary
  • Exchange
  • CYCC Nasdaq
  • JRSH Nasdaq
  • Market Cap
  • CYCC 47.6M
  • JRSH 44.5M
  • IPO Year
  • CYCC N/A
  • JRSH 2018
  • Fundamental
  • Price
  • CYCC $0.35
  • JRSH $3.03
  • Analyst Decision
  • CYCC Strong Buy
  • JRSH
  • Analyst Count
  • CYCC 1
  • JRSH 0
  • Target Price
  • CYCC $11.00
  • JRSH N/A
  • AVG Volume (30 Days)
  • CYCC 7.1M
  • JRSH 27.8K
  • Earning Date
  • CYCC 05-13-2025
  • JRSH 06-26-2025
  • Dividend Yield
  • CYCC 43.71%
  • JRSH 6.60%
  • EPS Growth
  • CYCC N/A
  • JRSH N/A
  • EPS
  • CYCC N/A
  • JRSH N/A
  • Revenue
  • CYCC $43,000.00
  • JRSH $138,135,034.00
  • Revenue This Year
  • CYCC $137.21
  • JRSH $29.89
  • Revenue Next Year
  • CYCC N/A
  • JRSH $8.30
  • P/E Ratio
  • CYCC N/A
  • JRSH N/A
  • Revenue Growth
  • CYCC N/A
  • JRSH 15.70
  • 52 Week Low
  • CYCC $0.17
  • JRSH $2.68
  • 52 Week High
  • CYCC $4.00
  • JRSH $4.17
  • Technical
  • Relative Strength Index (RSI)
  • CYCC 65.97
  • JRSH 46.17
  • Support Level
  • CYCC $0.23
  • JRSH $2.96
  • Resistance Level
  • CYCC $0.30
  • JRSH $3.15
  • Average True Range (ATR)
  • CYCC 0.06
  • JRSH 0.13
  • MACD
  • CYCC 0.01
  • JRSH 0.04
  • Stochastic Oscillator
  • CYCC 68.57
  • JRSH 63.64

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib.

About JRSH Jerash Holdings (US) Inc.

Jerash Holdings (US) Inc along with its subsidiaries is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers namely Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, Speedo etc. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.

Share on Social Networks: